Long-term remission of metastatic small cell carcinoma of the prostate.
Metastatic small cell carcinoma of the prostate portends a poor prognosis. Survival expectancy is generally estimated in months with few reports in the literature of patients surviving more than 2 years. We report a case of one of the longest known surviving patients in continuous complete remission with metastatic small cell carcinoma of the prostate and review the available literature reporting longer-term survival in this condition.
Ciszewski
Aleksandra
A
Division of Hematology and Medical Oncology and OHSU Cancer Institute, Oregon Health and Science University, Portland, Oregon 97239, USA.
Shackleton
Dustin
D
Beer
Tomasz M
TM
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000556:secondary*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000473:pathology*; D012074:Remission Induction; D017741:Survivors; D013997:Time Factors
D000970:Antineoplastic Agents